Bohan Zhang

Bohan Zhang

Auto-generated profile, based on publicly available information

Bohan Zhang

Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Nature Aging
Verified
Journal Article
Closed access
PDF file
VGVadim N Gladyshev
Vadim N Gladyshev
SKStephen B. Kritchevsky
Stephen B. Kritchevsky
SCSteven G. Clarke
Steven G. Clarke
ACAna Maria Cuervo
Ana Maria Cuervo
OFOliver Fiehn
Oliver Fiehn
SCSteven R. Cummings
Steven R. Cummings

11 August 2023 in Science
Verified
Journal Article
Closed access
AHAmin Haghani
Amin Haghani
CLCaesar Z. Li
Caesar Z. Li
TRTodd Robeck
Todd Robeck
JZJoshua Zhang
Joshua Zhang
ALAke T. Lu
Ake T. Lu
SHSteve Horvath
Steve Horvath
Using DNA methylation profiles ( n = 15,456) from 348 mammalian species, we constructed phyloepigenetic trees that bear marked similarities to traditional phylogenetic ones. Using unsupervised clustering across all samples, we identified 55 distinct cytosine modules, of which 30 are related to traits such as maximum life span, adult weight, age, sex, and human mortality risk. Maximum life span is associated with methylation levels in HOXL subclass homeobox genes and developmental processes and is potentially regulated by pluripotency transcription factors. The methylation state of some modules responds to perturbations such as caloric restriction, ablation of growth hormone receptors, consumption of high-fat diets, and expression of Yamanaka factors. This study reveals an intertwined evolution of the genome and epigenome that mediates the biological characteristics and traits of different mammalian species.

1 October 2020 in Aging Cell
Verified
Journal Article
Open access
PDF file
DRDidac Santesmasses Ruiz
Didac Santesmasses Ruiz
JCJosé Pedro Castro
José Pedro Castro
AZAleksandr A. Zenin
Aleksandr A. Zenin
ASAnastasia V. Shindyapina
Anastasia V. Shindyapina
MGMaxim V. Gerashchenko
Maxim V. Gerashchenko
VGVadim N Gladyshev
Vadim N Gladyshev
COVID‐19 is an ongoing pandemic caused by the SARS‐CoV‐2 coronavirus that poses one of the greatest challenges to public health in recent years. SARS‐CoV‐2 is known to preferentially target older subjects and those with pre‐existing conditions, but the reason for this age dependence is unclear. Here, we found that the case fatality rate for COVID‐19 grows exponentially with age in all countries tested, with the doubling time approaching that of all‐cause human mortality. In addition, men and those with multiple age‐related diseases are characterized by increased mortality. Moreover, similar mortality patterns were found for all‐cause pneumonia. We further report that the gene expression of ACE2, the SARS‐CoV‐2 receptor, grows in the lung with age, except for subjects on a ventilator. Together, our findings establish COVID‐19 as an emergent disease of aging, and age and age‐related diseases as its major risk factors. In turn, this suggests that COVID‐19, and deadly respiratory diseases in general, may be targeted, in addition to antiviral approaches, by approaches that target the aging process.

9 May 2024 in Nature Aging
Verified
Journal Article
Closed access
PDF file
ATAndrei E. Tarkhov
Andrei E. Tarkhov
TLThomas Lindstrom-Vautrin
Thomas Lindstrom-Vautrin
SZSirui Zhang
Sirui Zhang
KYKejun Ying
Kejun Ying
MMMahdi Moqri
Mahdi Moqri
VGVadim N Gladyshev
Vadim N Gladyshev

31 December 2021 in Aging Cell
Verified
Journal Article
Open access
PDF file
BZBohan Zhang
Bohan Zhang
ATAlexandre Trapp
Alexandre Trapp
CKCsaba Kerepesi
Csaba Kerepesi
VGVadim N Gladyshev
Vadim N Gladyshev
Several interventions have recently emerged that were proposed to reverse rather than just attenuate aging, but the criteria for what it takes to achieve rejuvenation remain controversial. Distinguishing potential rejuvenation therapies from other longevity interventions, such as those that slow down aging, is challenging, and these anti‐aging strategies are often referred to interchangeably. We suggest that the prerequisite for a rejuvenation intervention is a robust, sustained, and systemic reduction in biological age, which can be assessed by biomarkers of aging, such as epigenetic clocks. We discuss known and putative rejuvenation interventions and comparatively analyze them to explore underlying mechanisms.

1 January 2019 in Ageing Research Reviews
Verified
Journal Article
Closed access
FGFedor Galkin
Fedor Galkin
BZBohan Zhang
Bohan Zhang
SDSergey Dmitriev
Sergey Dmitriev
VGVadim N Gladyshev
Vadim N Gladyshev